We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Acupuncture for Infectious Mononucleosis Trial (AIM)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00598988
First Posted: January 23, 2008
Last Update Posted: October 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of Alberta
December 4, 2007
January 23, 2008
October 12, 2017
January 2008
December 2008   (Final data collection date for primary outcome measure)
Chalder Fatigue Questionnaire [ Time Frame: 12 weeks ]
Same as current
Complete list of historical versions of study NCT00598988 on ClinicalTrials.gov Archive Site
MOS SF-36 [ Time Frame: 12 weeks ]
Same as current
Not Provided
Not Provided
 
Acupuncture for Infectious Mononucleosis Trial
Acupuncture for Infectious Mononucleosis Trial
The purpose of this study is to investigate feasibility issues related to conducting an acupuncture study in a population of adolescents and young adults with infectious mononucleosis. Additionally, this study will provide preliminary data regarding treatment parameters (acupuncture and standard care) and outcomes (i.e. fatigue).
Not Provided
Interventional
Phase 2
Phase 3
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Infectious Mononucleosis
  • Procedure: traditional Chinese acupuncture
    10 treatments over 6 weeks
  • Other: standard medical care
    standard care as provided by primary physician
  • Experimental: A
    Traditional Chinese acupuncture in conjunction with standard medical care
    Intervention: Procedure: traditional Chinese acupuncture
  • Active Comparator: B
    standard medical care
    Intervention: Other: standard medical care
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
36
December 2008
December 2008   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • mono diagnosis confirmed by lab test
  • 21 days or less between start of symptoms and diagnostic test
  • presence of fatigue of at least 4/11 (by Chalder Fatigue Questionnaire)
  • no other illnesses present
  • meets residency requirement

Exclusion Criteria:

  • insufficient communication in English
  • unable to begin acupuncture within 21 days of diagnostic test
  • acupuncture use currently or in the preceding 3 months
  • currently under the care of a TCM practitioner
  • unwilling to be randomized
Sexes Eligible for Study: All
15 Years to 25 Years   (Child, Adult)
No
Contact information is only displayed when the study is recruiting subjects
Canada
 
 
NCT00598988
6866
Yes
Not Provided
Not Provided
Sunita Vohra/Dr, University of Alberta
University of Alberta
Not Provided
Principal Investigator: Sunita Vohra, MD, MSc University of Alberta
University of Alberta
January 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP